Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial

INTRODUCTION: Chronic hepatitis B (CHB) is a global public health problem. Antiviral therapy is the primary treatment. Studies have shown that a combined therapy of traditional Chinese medicine (TCM) and conventional antiviral drugs has better efficacy than conventional antiviral for treatment of CH...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qing-Juan, Lv, Wen-Liang, Li, Juan-Mei, Zhang, Ting-Ting, Zhou, Wen-hui, Zhang, Qiang, Wang, Jiu-Chong, Wang, Qing-Nan, Zhang, Ruo-Xuan, Zhao, Xin, Chen, Si-Tong, Liu, Shuang, Li, Gao-Hui, Cao, Zheng-Min, Xu, Lei, Chen, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275558/
https://www.ncbi.nlm.nih.gov/pubmed/32503608
http://dx.doi.org/10.1186/s13063-020-04395-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275558/
https://www.ncbi.nlm.nih.gov/pubmed/32503608
http://dx.doi.org/10.1186/s13063-020-04395-y

Ejemplares similares